COVID-19和心肌损伤:针对潜在的新疗法的高生物标志物
Pengyang Li1, Qun Chen1, Ion S Jovin1
1Virginia Commonwealth University, Richmond VA; McGuire VA Medical Center, Richmond VA.
Clinics (Sao Paulo, Brazil)
|August 28, 2024
概括
在住院患者中,COVID-19是导致热波水平升高的重要原因. 年龄,热素和C反应蛋白水平预测结果不佳,建议针对心肌损伤进行向治疗.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 由于COVID-19的流行,住院患者的心肌损伤的增加.
- 增加的氧化应激和炎症生物标志物与COVID-19相关的心肌损伤有关.
- 针对这些生物标志物的新疗法可能会改善结果.
研究的目的:
- 调查COVID-19的流行率作为心肌损伤患者的初级诊断.
- 为了确定COVID-19患者中死亡率的预测因素,这些患者血红素水平升高.
- 探索心脏生物标志物在COVID-19相关心肌损伤中的作用.
主要方法:
- 分析了2021年1月1日至12月31日期间的急诊室患者的热素测定结果.
- ICD-10诊断的分类和生物标志物升高的记录,用于高托罗邦素的入院患者.
- 确定COVID-19患者6个月随访期间死亡的独立预测因素.
主要成果:
- COVID-19是10%的心肌损伤患者的首要诊断.
- 在COVID-19患者中,死亡的独立预测因素包括年龄,峰值热素水平和峰值C反应蛋白 (CRP) 水平.
- 患有心肌损伤的COVID-19患者中有42%在6个月内死亡.
结论:
- 新诊断的COVID-19是没有1型心肌梗塞的住院患者中高托罗的常见原因.
- 年龄,峰值热素和峰值CRP水平是不良结果的独立预测因素.
- 用抗氧化剂或抗炎疗法向心脏生物标志物可能是有益的.
更多相关视频
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
16.7K
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.1K
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
119
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
68
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
68
